IR
65
-4
DVN
47
7
JBHT
60
-3
EXR
26
4
MET
66
2
NTAP
55
-3
SJM
12
-31
EMR
59
-5
SYY
48
-20
CNP
59
4
D
48
3
VRSN
43
-20
APH
43
-3
WEC
43
-27
IRM
31
-10
WM
57
-22
WMT
60
-15
TDC
63
-15
TXT
76
-4
AMAT
46
-4
IR
65
-4
DVN
47
7
JBHT
60
-3
EXR
26
4
MET
66
2
NTAP
55
-3
SJM
12
-31
EMR
59
-5
SYY
48
-20
CNP
59
4
D
48
3
VRSN
43
-20
APH
43
-3
WEC
43
-27
IRM
31
-10
WM
57
-22
WMT
60
-15
TDC
63
-15
TXT
76
-4
AMAT
46
-4
Financhill
Back

iShares Core US REIT ETF Vs. Ultragenyx Pharmaceutical, Inc. Industry Stock Comparison

Buy
65

USRT
iShares Core US REIT ETF

Last Price:
$56.81
Seasonality Move:
1.9%
Sell
23

RARE
Ultragenyx Pharmaceutical, Inc.

Last Price:
$32.84
Seasonality Move:
-0.96%
Buy
65
iShares Core US REIT ETF (USRT) is a Buy

Is iShares Core US REIT ETF a Buy, Sell or Hold?

  • The current iShares Core US REIT ETF [USRT] share price is $57.07. The Score for USRT is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
  • USRT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
23
Ultragenyx Pharmaceutical, Inc. (RARE) is a Sell

Is Ultragenyx Pharmaceutical, Inc. a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical, Inc. [RARE] share price is $33.21. The Score for RARE is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

USRT Stock Price Chart

What is iShares Core US REIT ETF's stock price today?

  • The iShares Core US REIT ETF share price today is $57.07
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and USRT is experiencing slight buying pressure.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical, Inc.'s stock price today?

  • The Ultragenyx Pharmaceutical, Inc. share price today is $33.21
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RARE is experiencing selling pressure, which indicates risk of future bearish movement.

USRT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.55 Buy
Relative Strength Index (14 RSI): 42.44 Sell
Chaikin Money Flow: 79687 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (57.26 - 58.36) Sell
Bollinger Bands (100): (56.91 - 58.71) Sell

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.65 Buy
Relative Strength Index (14 RSI): 43.13 Sell
Chaikin Money Flow: -1062961 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (32.65 - 35.95) Sell
Bollinger Bands (100): (29.01 - 34.13) Buy

USRT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.36 Sell
20-day SMA: 57.81 Sell
50-day SMA: 58.01 Sell
200-day SMA: 57.2 Sell
8-day EMA: 12.68 Buy
20-day EMA: 5.44 Buy
50-day EMA: 2.24 Buy
200-day EMA: 0.57 Buy

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 35.62 Sell
20-day SMA: 34.63 Sell
50-day SMA: 33.66 Sell
200-day SMA: 33.65 Sell
8-day EMA: 7.38 Buy
20-day EMA: 3.16 Buy
50-day EMA: 1.3 Buy
200-day EMA: 0.33 Buy

iShares Core US REIT ETF Earnings Growth & USRT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Ultragenyx Pharmaceutical, Inc. Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.39 per share, and an increase next year of $1.31 per share.

iShares Core US REIT ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):